The 7th Annual World CDx Boston Summit 2016 offered end to end content dedicated to help attendees rapidly progress from exploratory biomarker to registrational CDx, align clinical co-development and ensure reimbursement and market access success for their precision therapies and assays.
The event also helped attendees to:
- Understand the cost/benefit analysis to decide when and how to embark on a full CDx strategy. Overcome trial design, patient recruitment and data challenges to ensure rapid and aligned clinical co-development:
- Navigate constantly evolving regulatory guidelines and prepare for market access, reimbursement & health economics challenges on a global scale. Ensure you have done your due diligence with your partners to achieve maximum value.
Attendees of the event enjoyed senior level networking and unrivaled learning, and help defining their most efficient CDx roadmap.